ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors
Acta Neuropathologica · 14.08.2024 · 148 (1)
DOI: 10.1007/s00401-024-02785-z ↗Kurz gefasst
Leserbrief in der Zeitschrift Acta Neuropathologica, online erschienen am 14.08.2024. Verfasst von Kevin Y Zhang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, 1800 Orleans St, Baltimore, MD, 21287, USA. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Histones, Repressor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University School of Medicine, 1800 Orleans St, Baltimore, MD, 21287, USA.
- Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, USA.
- Department of Pathology, Johns Hopkins All Children's Hospital, Saint Petersburg, USA.
- Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, USA.
- Department of Radiation Oncology, Sibley Memorial Hospital, Washington, USA.
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA.
ORCID-Profile: Calixto-Hope G Lucas
Förderung
- NCI NIH HHS
Zitieren
APA
Zhang, K. Y., Parker, M., Weber-Levine, C., Kalluri, A., Gonzalez-Gomez, I., Raabe, E., Dudley, J. C., Gocke, C., Lin, M. T., Zou, Y., Sherief, M., Kamson, D. O., Holdhoff, M., Mukherjee, D., Croog, V., Schreck, K. C., Rincon-Torroella, J., Bettegowda, C., Eberhart, C. G., …, & Lucas, C. G. (2024). ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors. Acta Neuropathologica, 148(1). https://doi.org/10.1007/s00401-024-02785-z
Vancouver
Zhang KY, Parker M, Weber-Levine C, Kalluri A, Gonzalez-Gomez I, Raabe E, et al. ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors. Acta Neuropathologica. 2024;148(1). doi:10.1007/s00401-024-02785-z
BibTeX
@article{Zhang2024,
author = {Zhang, Kevin Y and Parker, Megan and Weber-Levine, Carly and Kalluri, Anita and Gonzalez-Gomez, Ignacio and Raabe, Eric and Dudley, Jonathan C and Gocke, Christopher and Lin, Ming-Tseh and Zou, Ying and Sherief, Mohamed and Kamson, David O and Holdhoff, Matthias and Mukherjee, Debraj and Croog, Victoria and Schreck, Karisa C and Rincon-Torroella, Jordina and Bettegowda, Chetan and Eberhart, Charles G and Bale, Tejus and Lucas, Calixto-Hope G},
title = {ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors},
journal = {Acta Neuropathologica},
year = {2024},
volume = {148},
number = {1},
doi = {10.1007/s00401-024-02785-z}
}
EUVIMED